CD8A and neoplasm: Six days after tumour challenge, young mice in which donor OT-II cells had been primed, induced OVA-specific CD8+ T cells in tumour-draining LNs and in tumour more efficiently than mice possessing naive OT-II cells without DC vaccination, regardless of anti-IL-6 Ab treatment (Fig. 7c–e; Supplementary Fig. 4).